Wordt geladen...
Quizartinib for the treatment of FLT3/ITD acute myeloid leukemia
FLT3/ITD acute myeloid leukemia is a poor prognosis disease driven by a constitutively activated receptor tyrosine kinase, making it an obvious target for drug development. The development of clinically effective FLT3 inhibitors has been slow, in part because many are multi-targeted inhibitors that...
Bewaard in:
| Gepubliceerd in: | Future Oncol |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6081740/ https://ncbi.nlm.nih.gov/pubmed/25145428 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon.14.105 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|